Multipoint Pacing Versus Cardiac Resynchronization Therapy in Heart Failure: A Systematic Review and Meta‐Analysis
Pacing and Clinical Electrophysiology · 2026-08 · 49 (8) · 1074-1085
DOI: 10.1111/pace.70259 ↗At a glance
Systematische Übersicht in Pacing and Clinical Electrophysiology, published online on 2026-04-18. Written by Fahad Muhammad and 4 co-authors. Institution: Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK. Major MEDLINE topics: Heart Failure, Cardiac Resynchronization Therapy, Cardiac Pacing, Artificial. 24 references. The full text is freely available (open access, CC BY 4.0).
Topics: Herzinsuffizienz
Abstract (original language)
Introduction
Multipoint pacing (MPP) delivers sequential stimuli from multiple left‐ventricular electrodes, potentially improving cardiac resynchronization therapy (CRT) response versus conventional biventricular pacing (BiV). We performed an updated systematic review and meta‐analysis to synthesize contemporary evidence.
Methods
Following PRISMA 2020 (PROSPERO CRD420261293273), MEDLINE, EMBASE, and CENTRAL were searched to January 2026 for comparative studies of MPP versus conventional BiV in adults receiving CRT. Primary outcomes were all‐cause mortality and heart failure (HF)‐related hospitalization. Secondary outcomes included echocardiographic response, NYHA class improvement, and absolute change in left‐ventricular ejection fraction (LVEF). Random‐effects models produced pooled odds ratios (OR) or mean differences (MD).
Results
Eight studies ( n = 2430; 1190 MPP, 1240 BiV), including five randomized and three observational studies, were analyzed. All‐cause mortality showed no significant difference between groups (OR = 1.46, 95% CI 0.76–2.80; p = 0.25; I 2 = 0%). HF‐related hospitalization was significantly reduced with MPP in the largest trial (5.4% vs. 8.9%; p = 0.015), corresponding to a 39% relative risk reduction. MPP was associated with significantly higher echocardiographic response (OR = 0.43, 95% CI 0.29–0.64; p < 0.0001; I 2 = 0%), greater NYHA class improvement (OR = 0.38, 95% CI 0.20–0.73; p = 0.004; I 2 = 3%), and greater absolute LVEF (MD = −4.67, 95% CI −6.70 to −2.64; p < 0.00001; I 2 = 0%).
Conclusions
Compared with conventional CRT, MPP was associated with improved functional and echocardiographic outcomes and reduced HF hospitalization, without a demonstrated mortality benefit. Larger prospective studies with longer follow‐up are required to assess long‐term prognostic effects.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
- School of Medicine, University of Central Lancashire, England, Preston, UK.
- Royal Blackburn Teaching Hospital, East Lancashire Hospitals Trust, England, Blackburn, UK.
- School of Medicine, Queen's University Belfast, Northern Ireland, Belfast, UK.
- School of Medicine, University of Sheffield, England, Sheffield, UK.
- Department of Cardiology, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester, UK.
Cite
APA
Muhammad, F., AlMeer, M., Jamileh, E., Elmewafy, A., & Antoun, I. (2026). Multipoint Pacing Versus Cardiac Resynchronization Therapy in Heart Failure: A Systematic Review and Meta‐Analysis. Pacing and Clinical Electrophysiology, 49(8), 1074-1085. https://doi.org/10.1111/pace.70259
Vancouver
Muhammad F, AlMeer M, Jamileh E, Elmewafy A, Antoun I. Multipoint Pacing Versus Cardiac Resynchronization Therapy in Heart Failure: A Systematic Review and Meta‐Analysis. Pacing and Clinical Electrophysiology. 2026;49(8):1074-1085. doi:10.1111/pace.70259
BibTeX
@article{Muhammad2026,
author = {Muhammad, Fahad and AlMeer, Mohammad and Jamileh, Eyad and Elmewafy, Ahmed and Antoun, Ibrahim},
title = {Multipoint Pacing Versus Cardiac Resynchronization Therapy in Heart Failure: A Systematic Review and Meta‐Analysis},
journal = {Pacing and Clinical Electrophysiology},
year = {2026},
volume = {49},
number = {8},
pages = {1074--1085},
doi = {10.1111/pace.70259}
}
EUVIMED